Effects of melanocortin receptor activation and blockade on ethanol intake: a possible role for the melanocortin-4 receptor.
BACKGROUND
The melanocortin (MC) system is composed of peptides that are cleaved from the polypeptide precursor pro-opiomelanocortin. A growing body of literature suggests that the MC system modulates neurobiological responses to drugs of abuse. Because ethanol has direct effects on central pro-opiomelanocortin activity, it is possible that MC neuropeptides participate in the control of voluntary ethanol consumption. Here we assessed the possibility that MC receptor (MCR) agonists modulate ethanol intake via the MC3 receptor (MC3R) and/or the MC4 receptor (MC4R) and whether the MCR antagonist AgRP-(83-132) controls ethanol consumption.


METHODS
Mc3r-deficient (Mc3r) and wild-type (Mc3r) littermate mice were given intraperitoneal (10 mg/kg) and intracerebroventricular (1.0 microg ICV) doses of melanotan II (MTII), a nonselective MCR agonist. To assess the role of MC4R, C57BL/6J mice were given an ICV infusion of the highly selective MC4R agonist cyclo(NH-CH2-CH2-CO-His-d-Phe-Arg-Trp-Glu)-NH2 (1.0 or 3.0 microg). Finally, naïve C57BL/6J mice were given an ICV infusion of AgRP-(83-132) (0.05 and 1.0 microg).


RESULTS
MTII was similarly effective at reducing ethanol drinking in Mc3r-deficient (Mc3r) and wild-type (Mc3r) littermate mice. Furthermore, ICV infusion of the MC4R agonist significantly reduced ethanol drinking, whereas ICV infusion of AgRP-(83-132) significantly increased ethanol drinking in C57BL/6J mice. Neither MTII nor AgRP-(83-132) altered blood ethanol levels at doses that modulated ethanol drinking.


CONCLUSIONS
The present results suggest that MC4R, and not MC3R, modulates MCR agonist-induced reduction of ethanol consumption and that ethanol intake is increased by the antagonistic actions of AgRP-(83-132). These findings strengthen the argument that MCR signaling controls ethanol consumption and that compounds directed at MCR may represent promising targets for treating alcohol abuse disorders in addition to obesity.
Navarro
Montserrat
M
Department of Psychology, University of North Carolina, Chapel Hill, North Carolina 27599, USA.
Cubero
Inmaculada
I
Chen
Airu S
AS
Chen
Howard Y
HY
Knapp
Darin J
DJ
Breese
George R
GR
Marsh
Donald J
DJ
Thiele
Todd E
TE
D054369:Agouti-Related Protein; D000428:Alcohol Drinking / Q000517:prevention & control*; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects* / Q000502:physiology; D004435:Eating / Q000187:drug effects / Q000502:physiology; D000431:Ethanol / Q000009:adverse effects* / Q000097:blood; D005260:Female; D005838:Genotype; D008297:Male; D051379:Mice; D010446:Peptide Fragments / Q000494:pharmacology; D010456:Peptides, Cyclic / Q000494:pharmacology; D044105:Receptor, Melanocortin, Type 4 / Q000187:drug effects / Q000502:physiology; D044101:Receptors, Melanocortin / Q000187:drug effects* / Q000502:physiology; D000521:alpha-MSH / Q000031:analogs & derivatives / Q000494:pharmacology
D054369:Agouti-Related Protein; D010446:Peptide Fragments; D010456:Peptides, Cyclic; D044105:Receptor, Melanocortin, Type 4; D044101:Receptors, Melanocortin; C430443:agouti-related protein (86-132), human; C079282:melanotan-II; D000431:Ethanol; D000521:alpha-MSH